Potential anti-liver cancer targets and mechanisms of kaempferitrin based on network pharmacology, molecular docking and experimental verification

药物数据库 计算生物学 小桶 肝癌 对接(动物) 生物信息学 生物 交互网络 癌症 癌症研究 基因 药理学 生物化学 转录组 基因表达 医学 遗传学 护理部 药品
作者
Siyu Zhou,Huidong Zhang,Jiao Li,Wei Li,Min Su,Yi Ren,Fengjun Ge,Hong Zhang,Hongli Shang
出处
期刊:Computers in Biology and Medicine [Elsevier]
卷期号:178: 108693-108693
标识
DOI:10.1016/j.compbiomed.2024.108693
摘要

Kaempferitrin is an active component in Chenopodium ambrosioides, showing medicinal functions against liver cancer. This study aimed to identify the potential targets and pathways of kaempferitrin against liver cancer using network pharmacology and molecular docking, and verify the essential hub targets and pathway in mice model of SMMC-7721 cells xenografted tumors and SMMC-7721 cells. Kaempferitrin therapeutical targets were obtained by searching SwissTargetPrediction, PharmMapper, STITCH, DrugBank, and TTD databases. Liver cancer specific genes were obtained by searching GeneCards, DrugBank, TTD, OMIM, and DisGeNET databases. PPI network of "kaempferitrin-targets-liver cancer" was constructed to screen the hub targets. GO, KEGG pathway and MCODE clustering analyses were performed to identify possible enrichment of genes with specific biological subjects. Molecular docking and molecular dynamics simulation were employed to determine the docking pose, potential and stability of kaempferitrin with hub targets. The potential anti-liver cancer mechanisms of kaempferitrin, as predicted by network pharmacology analyses, were verified by in vitro and in vivo experiments. 228 kaempferitrin targets and 2186 liver cancer specific targets were identified, of which 50 targets were overlapped. 8 hub targets were identified through network topology analysis, and only SIRT1 and TP53 had a potent binding activity with kaempferitrin as indicated by molecular docking and molecular dynamics simulation. MCODE clustering analysis revealed the most significant functional module of PPI network including SIRT1 and TP53 was mainly related to cell apoptosis. GO and KEGG enrichment analyses suggested that kaempferitrin exerted therapeutic effects on liver cancer possibly by promoting apoptosis via p21/Bcl-2/Caspase 3 signaling pathway, which were confirmed by in vivo and in vitro experiments, such as HE staining of tumor tissues, CCK-8, qRT-PCR and western blot. This study provided not only insight into how kaempferitrin could act against liver cancer by identifying hub targets and their associated signaling pathways, but also experimental evidence for the clinical use of kaempferitrin in liver cancer treatment.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
顾矜应助leec采纳,获得20
刚刚
pride应助气945采纳,获得10
1秒前
奋斗的绝悟完成签到,获得积分10
1秒前
假面绅士发布了新的文献求助10
2秒前
3秒前
Rachel发布了新的文献求助10
3秒前
善学以致用应助后知后觉采纳,获得10
3秒前
11发布了新的文献求助10
3秒前
司空笑白发布了新的文献求助10
4秒前
温暖的绝悟完成签到 ,获得积分10
5秒前
6秒前
搜集达人应助科研通管家采纳,获得10
6秒前
Jasper应助科研通管家采纳,获得10
6秒前
丘比特应助科研通管家采纳,获得10
6秒前
6秒前
6秒前
lyl19880908应助科研通管家采纳,获得10
6秒前
烟花应助科研通管家采纳,获得10
6秒前
慕青应助科研通管家采纳,获得10
6秒前
隐形曼青应助科研通管家采纳,获得10
6秒前
我是老大应助科研通管家采纳,获得10
6秒前
完美世界应助科研通管家采纳,获得10
7秒前
打打应助科研通管家采纳,获得10
7秒前
Jasper应助科研通管家采纳,获得10
7秒前
领导范儿应助科研通管家采纳,获得10
7秒前
科研通AI2S应助科研通管家采纳,获得10
7秒前
NexusExplorer应助科研通管家采纳,获得10
7秒前
CipherSage应助科研通管家采纳,获得10
7秒前
7秒前
7秒前
7秒前
Bryan应助专一的新之采纳,获得10
7秒前
猫毛完成签到,获得积分10
7秒前
愉快的楷瑞完成签到,获得积分10
8秒前
8秒前
8秒前
LMa发布了新的文献求助10
9秒前
9秒前
10秒前
桐桐应助咖啡不苦采纳,获得10
10秒前
高分求助中
The ACS Guide to Scholarly Communication 2500
Sustainability in Tides Chemistry 2000
Pharmacogenomics: Applications to Patient Care, Third Edition 1000
Studien zur Ideengeschichte der Gesetzgebung 1000
TM 5-855-1(Fundamentals of protective design for conventional weapons) 1000
Threaded Harmony: A Sustainable Approach to Fashion 810
Genera Insectorum: Mantodea, Fam. Mantidæ, Subfam. Hymenopodinæ (Classic Reprint) 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3082954
求助须知:如何正确求助?哪些是违规求助? 2736245
关于积分的说明 7540502
捐赠科研通 2385654
什么是DOI,文献DOI怎么找? 1265037
科研通“疑难数据库(出版商)”最低求助积分说明 612909
版权声明 597693